Skip to main content

Table 3 Discordance of QTF and TST results in each group, excluding patients with indeterminate QTF results

From: Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists

  

RA-TNF1 (n= 36)

RA-TNF2 (n= 38)

TNF-naive RA

(n= 39)

TB

(n= 28)

LEPROSY

(n= 22)

Healthy controls (n= 41)

Total

(n= 204)

QTF (+)

TST (+)

5 (13%)

9 (24%)

15 (38%)

12 (40%)

12 (52%)

16 (39%)

69 (34%)

 

TST (-)

8 (21%)

7 (18%)

5 (13%)

3 (10%)

2 (9%)

3 (7%)

28 (14%)

QTF (-)

TST (+)

4 (11%)

5 (13%)

6 (15%)

3 (10%)

1 (4%)

12 (29%)

31 (15%)

 

TST (-)

19 (50%)

17 (45%)

13 (33%)

10 (33%)

7 (30%)

10 (24%)

76 (36%)

  1. Tuberculin skin test (TST) positivity is defined as an induration of ≥ 10 mm.